This inventor holds 12 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Taigen Biotechnology Company, Ltd., Taigen Biotechnology, Taigen Biopharmaceuticals Co.(beijing), Ltd.. Active years: 2008-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Taipei County, TW (2012 - 2013)
- New Taipei, TW (2016)
- Taipei, TW (2008 - 2024)
Company Filing History:
9 out of 16 
3 out of 5 
2 out of 2 Years Active: 2008-2024
Title: **Innovations of Inventor Chi-Feng Yen**
Introduction
Chi-Feng Yen is a renowned inventor based in Taipei, Taiwan. With an impressive portfolio of 12 patents, he has made significant contributions to the field of pharmaceutical formulations and synthesis processes. His work primarily focuses on developing innovative solutions for viral infections and the synthesis of complex compounds.
Latest Patents
Among his latest patents, two notable innovations stand out. The first is an **Amorphous Solid Dispersion Formulation**, which features a Cap-dependent endonuclease inhibitor or a pharmaceutically acceptable salt dispersed in a matrix formed from a pharmaceutically acceptable polymer. This formulation is intended for oral administration, and the patent also outlines methods for preparing this dispersion, focusing on its use in treating viral infections.
The second notable patent is related to the **Stereoselective Synthesis of Intermediate for Preparation of Heterocyclic Compound**. This process represents a significant advancement, simplifying the synthesis of intermediates required for developing heterocyclic derivatives that serve as Cap-dependent endonuclease inhibitors. The benefits of this method include higher yield, simple operation, and manageable stereoselectivity, making it suitable for large-scale production.
Career Highlights
Throughout his career, Chi-Feng Yen has worked with esteemed companies, including Taigen Biotechnology Company, Ltd. and Taigen Biotechnology. His experience in these organizations has played a vital role in the development and commercialization of innovative biopharmaceutical products.
Collaborations
Chi-Feng has collaborated with notable colleagues in his field, including Ying-Huey Huang and Chi-Hsin Richard King. Together, they have contributed to advancements in pharmaceutical research and development, leveraging their combined expertise to enhance therapeutic options.
Conclusion
Chi-Feng Yen's contributions to innovation in the pharmaceutical industry make him a significant figure in the development of treatments for viral infections and complex chemical syntheses. His ongoing research and patent portfolio continue to pave the way for cutting-edge medical solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile